FENC
NASDAQ
$10.39
Fennec Pharmaceuticals Inc (FENC)
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States. The company is headquartered in Research Triangle Park, North Carolina.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $15.67 (+50.82%)
Market Cap
$366M
Revenue 5Y CAGR
+202.90%
Free Cash Flow Yield
-1.58%
Beta (5Y)
1.03
Price Chart
Valuation
Market Cap$366M
Forward P/E41.32
PEG1.47
P/S7.60
P/B10.30
Profitability
Total Revenue (TTM)$51M
Gross Profit (TTM)$47M
EBITDA-$6.77M
Profit Margin1.3%
Operating Margin-0.8%
EPS-$0.27
Financial Health
Free Cash Flow Yield-1.58%
Growth & Risk
EPS 5Y CAGR-19.60%
Revenue 5Y CAGR+202.90%
FCF 5Y CAGR-17.85%
Beta (5Y)1.03
Sharpe Ratio0.44